Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)
Clinical trial NCT02478229 · TERMINATED
Trial details
- NCT number
- NCT02478229
- Sponsor
- University Health Network, Toronto
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-04-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.